With the growing phenomena of engineering antibodies to enhance function, potency, stability and specific targeting, Informa Life Sciences' would like to welcome you to Europe's leading platform for industry, academia and technology providers. The Empowered Antibodies Congress provides unrivalled networking opportunities and the chance to discuss the latest techniques for improvement/enhancement, antibody platforms and preclinical/clinical updates on production of these next generation products.
Our 2012 congress provided an unrivalled opportunity for industry, academia and service providers to access professionals in the 3 key antibody universes to discover the latest scientific know-how, benchmark against cutting-edge engineering technologies and the opportunity to hear the latest industry bottlenecks in development.
Take a look at what happened at the Empowered Antibodies 2012 Congress:
Our exhibition fall was full throughout the two days with exhibitors and industry professionals discussing thei latest product development as well as the current products/services that are currently available to improve product engineering.
Informa hosted a designated poster area for those academics or industry professionals to demonstrate their latest work through a poster. Informa are looking to grow our poster session for next year, so please do get in touch if you would like to contribute a poster at our 2013 event.
Just one of our interactive discussion panels including some of our many antibody engineering experts. This particular panel was at the ADC meeting (left to right: Dr Jan Pinkas, Director, Pharmacology, Immunogen, Dr Arnout Gerritsen, Associate Director, Bioanalysis, Genmab, Dr Kyle Bryan, VP, Medical Affairs, Seattle Genetics & Dr David Maio, CSO/Co-founder, Concortis Biosystems).